At Articulus, we are driven by the mission to provide better surgical outcomes to 170 Million patients through affordable and accessible minimally invasive surgical robotics. We believe that every patient deserves better surgical outcomes and every surgeon deserves the tools, technology, and training to make this possible. Our patent-pending product and control system is poised to revolutionize surgical robotics, with a hybrid surgical robot that is 5x more affordable, and 5x more portable compared to the competition while providing state-of-the-art dexterity, precision and ease of learning. Our product is designed to be interoperable with the existing infrastructure of hospitals thereby making on-demand surgical robotics a reality. We are going beyond cost-effectiveness and are leveraging the power of Assistive Intelligence to ensure surgeries are safer and more predictable and to ultimately become the gateway to a true amalgamation of Surgeon, Robot and AI. Our asset-light business model allows us to serve a $40 billion global market, expanding our reach to 5 times more hospitals and clinics than any of our competitors, providing us with a unique opportunity to make a significant impact. In the next decade, we expect one-third of surgeries to be performed using robotics. Articulus is poised to fill the gap left by inadequate current solutions and become a mission-critical asset in surgery.
